Nov 17, 2025 08:05AM
Oct 29, 2025 08:25AM
Oct 29, 2025 06:09AM
Oct 23, 2025 08:45AM
Oct 8, 2025 08:45AM
Oct 6, 2025 08:10AM
Sep 9, 2025 09:10AM Silo Pharma receives Japanese patent for licensed PTSD drug SPC-15
Sep 3, 2025 08:25AM
Aug 21, 2025 02:00PM
Aug 19, 2025 08:05AM
Aug 5, 2025 08:32AM
Jul 16, 2025 08:45AM
Jul 7, 2025 08:16AM
Jun 25, 2025 08:38AM Silo Pharma (SILO) Enters into Letter of Intent to Form Joint Venture with Hoth Therapeutics to Develop Obesity Treatment Targeting $16 Billion Global Market
Jun 25, 2025 08:29AM
Jun 11, 2025 09:03AM
Jun 5, 2025 09:32AM
Jun 5, 2025 09:15AM
May 21, 2025 08:56AM
May 15, 2025 09:15AM
May 14, 2025 04:08PM Silo Pharma (SILO) Selects Veloxity Labs for Bioanalytical IND-Enabling Study for SPC-15
May 14, 2025 08:40AM
Apr 30, 2025 08:11AM
Apr 28, 2025 07:50AM
Mar 26, 2025 08:43AM
Feb 26, 2025 01:30PM
Feb 18, 2025 08:51AM
Feb 11, 2025 07:45AM Silo Pharma (SILO) Announces Positive Initial Pharmacokinetic, Safety, and Tolerability Study of SP-26
Jan 22, 2025 08:29AM
Jan 8, 2025 08:29AM
Jan 2, 2025 08:45AM
Dec 18, 2024 07:36AM
Nov 29, 2024 08:05AM
Nov 18, 2024 08:40AM
Sep 10, 2024 06:36AM Silo Pharma (SILO) Announces Completion of FDA Pre-IND Meeting to Advance Development of SPC-15 for Treatment of PTSD
Aug 14, 2024 02:32PM
Aug 7, 2024 08:14AM
Jul 19, 2024 08:01AM
Jul 18, 2024 08:25AM
Jul 17, 2024 04:48PM
Jul 16, 2024 06:30AM
Jul 8, 2024 08:45AM Silo Pharma, Inc. (SILO) Enters Exclusive, Global License for Lead Candidate SPC-15 Targeting PTSD and Stress-Induced Anxiety Disorders
Jun 26, 2024 08:51AM

353,174 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All